Brief: Freeline Presents Data On Its Gaucher Disease And Fabry Disease Aav-Based Gene Therapies At The 17Th Annual Worldsymposium™
08/02/2021 21:37
Feb 8 (Reuters) - Freeline Therapeutics Holdings PLC
FRLN.O :
* FREELINE PRESENTS DATA ON ITS GAUCHER DISEASE AND FABRY
DISEASE
AAV-BASED GENE THERAPIES AT THE 17TH ANNUAL WORLDSYMPOSIUM™
* FREELINE THERAPEUTICS HOLDINGS - FIRST-IN-HUMAN DOSE
FINDING
STUDIES OF FLT201 ON-TRACK FOR INITIATION IN LATE 2021
Source text for Eikon: ID:nGNX3xJdHj
Further company coverage: FRLN.O
((Reuters.Briefs@thomsonreuters.com;))